Philips’ Post

𝐀 𝐬𝐡𝐢𝐟𝐭 𝐭𝐨𝐰𝐚𝐫𝐝 𝐝𝐢𝐠𝐢𝐭𝐚𝐥 𝐫𝐞𝐜𝐨𝐯𝐞𝐫𝐲 𝐢𝐬 𝐫𝐞𝐬𝐡𝐚𝐩𝐢𝐧𝐠 𝐬𝐩𝐨𝐫𝐭𝐬 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞, 𝐛𝐮𝐭 𝐢𝐝𝐞𝐧𝐭𝐢𝐟𝐲𝐢𝐧𝐠 𝐭𝐡𝐞 𝐫𝐢𝐠𝐡𝐭 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬 𝐢𝐬 𝐨𝐟𝐭𝐞𝐧 𝐭𝐡𝐞 𝐡𝐚𝐫𝐝𝐞𝐬𝐭 𝐩𝐚𝐫𝐭. Considering this challenge, a global sports OEM engaged Stellarix to map the digital rehabilitation landscape and identify high-potential partners. 𝐅𝐢𝐧𝐚𝐥 𝐈𝐦𝐩𝐚𝐜𝐭? The client accelerated its external innovation strategy, simplified partner screening, and minimized technology development risk through a practical roadmap. 𝐅𝐨𝐫 𝐜𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐝𝐞𝐭𝐚𝐢𝐥𝐬: https://lnkd.in/gN-4MTpC #stellarix #clientsuccessstories #medicaldevices #sportsmedicine

As the excitement of the 𝐅𝐈𝐅𝐀 𝐖𝐨𝐫𝐥𝐝 𝐂𝐮𝐩 grips billions of fans worldwide, investors may want to look beyond the action on the field. While 𝐀𝐈 continues to dominate headlines, 𝐒𝐩𝐨𝐫𝐭𝐬 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 is quietly emerging as another high-potential investment theme. The 𝐠𝐥𝐨𝐛𝐚𝐥 𝐬𝐩𝐨𝐫𝐭𝐬 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐦𝐚𝐫𝐤𝐞𝐭, 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐚𝐫𝐨𝐮𝐧𝐝 𝐔𝐒𝐃 6.2 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024, is expected to 𝐠𝐫𝐨𝐰 𝐚𝐭 6.5–7% 𝐂𝐀𝐆𝐑, driven by rising sports participation, active aging populations, increasing musculoskeletal injuries, and demand for faster recovery. The industry is also benefiting from innovations in biologics, robotic-assisted surgery, regenerative medicine, wearables, and AI-powered injury prevention. Public market leaders include 𝐉𝐨𝐡𝐧𝐬𝐨𝐧 & 𝐉𝐨𝐡𝐧𝐬𝐨𝐧 (𝐍𝐘𝐒𝐄: 𝐉𝐍𝐉) 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐃𝐞𝐏𝐮𝐲 𝐒𝐲𝐧𝐭𝐡𝐞𝐬, 𝐒𝐭𝐫𝐲𝐤𝐞𝐫 (𝐍𝐘𝐒𝐄: 𝐒𝐘𝐊), 𝐙𝐢𝐦𝐦𝐞𝐫 𝐁𝐢𝐨𝐦𝐞𝐭 (𝐍𝐘𝐒𝐄: 𝐙𝐁𝐇), 𝐒𝐦𝐢𝐭𝐡+𝐍𝐞𝐩𝐡𝐞𝐰 (𝐋𝐒𝐄: 𝐒𝐍), 𝐚𝐧𝐝 𝐀𝐫𝐭𝐡𝐫𝐞𝐱 (𝐩𝐫𝐢𝐯𝐚𝐭𝐞), all of which are investing heavily in minimally invasive procedures, sports injury repair, and digital orthopedics. The next decade's winners may not just be the companies building intelligent machines but also those keeping athletes, weekend runners, and aging populations moving.

Meet lab-to-market success story Sit Sense. The MSU born and SmartZone supported venture is disrupting a critical area of the medtech field by addressing the persistent issue of pressure sores in patients with mobility issues. Read more about their journey here: https://hubs.la/Q04mGRJ20

How do you take an idea and turn it into a commercial reality? Professor Karen Reynolds - Director of Flinders Factory of the Future, and founder and director of Flinders University’s Medical Device Partnering Program - shares her insights with Lot Fourteen's Boundless magazine on what it takes to move an idea from concept to market. She explains how the expertise, industry connections and innovation support available through Flinders Factory of the Future and its flagship program, FORGE, can help organisations accelerate their journey from idea to impact. Read more: https://lnkd.in/gXaazaD7

The strength of UK HealthTech lies in its expertise, and the value of bringing that expertise together. 🗨️ Across ABHI's member groups, companies share insight, discuss the challenges and opportunities affecting their work, and help inform our engagement with government, regulators and the NHS. From value and access, regulation and digital health to diagnostics, robotics, SMEs and international growth, our member groups provide a space to connect with peers, contribute your expertise and help shape the conversations influencing the future direction of UK HealthTech. Explore our member groups and find out how to get involved 👇 https://lnkd.in/ew-kH6QR Not yet an ABHI member? Learn more about joining our community and adding your voice to the conversation: https://lnkd.in/dmnHsPtE

Every new season starts with one goal: being ready. Before the first whistle, performance begins with measurement. ⠀⠀⠀ Juventus Football Club players undergo comprehensive pre-season assessments supported by COSMED technology at Jmedical center. By measuring physiological responses during exercise, sports scientists gain the insights needed to evaluate fitness, personalize training, and monitor every athlete's readiness for the challenges ahead. ⠀⠀⠀ When every detail counts, trusted data makes the difference. Measure what matters. ⠀⠀⠀ Discover how COSMED solutions empower sports science professionals: https://shorturl.at/JNSpt

Why is it that some medical innovations have seen widespread adoption despite known limitations, while other well-evidenced and effective innovations take decades to become clinical practice, if ever? Exploring this question further in an article for MedTech Spectrum, Robert McLeay, a doctor and former founder of DoseMe, elaborates on three factors that must be met for the acceptance and adoption of new innovations. Read the article here 👉 https://lnkd.in/gh6hWGwV

Earlier this year at the HIMSS Europe conference in Copenhagen Founda participated in the Interoperability Showcase organized by IHE-Europe. Together with ENT - Ericsson Nikola Tesla and Helix Health Founda participated in a cross-border health information exchange use-case demonstrating how a Danish doctor is able to pull up an "European Patient Summary" of traveler Jon who visits Denmark from Iceland. A full recording of the showcase demonstration is available via: https://lnkd.in/e8i-YXDM. In the video we explain which IHE profiles are used to exchange data between Iceland (🇮🇸) and Denmark (🇩🇰)via two National Contact Point gateways. #interoperabilityisamindset, #ehds

⬇ Great few days at HLTH Europe 2026 in Amsterdam! ⬇ We were proud to showcase TECNALIA’s capabilities in smart medical devices, connecting with healthcare leaders, innovators and industry partners from across the international health ecosystem. From AI-powered diagnostics and connected devices to remote patient monitoring and medical robotics, we are helping companies bring innovative healthcare solutions from concept to market faster and more safely. ▶ Our colleagues attended this event: Nerea Briz Iceta, Director of Health at TECNALIA Manuel Montejo goran bijelic Borja Bonail Anthony Remazeilles 👏👏👏Thank you to everyone who visited us and shared insights on the future of healthcare innovation. We look forward to continuing the conversations and building new collaborations. More informaticion 👇👇👇👇👇👇 https://lnkd.in/emVfrcmh #SmartMedicalDevices